Provided by Tiger Fintech (Singapore) Pte. Ltd.

4D Molecular Therapeutics

4.35
+0.440011.25%
Post-market: 4.350.00000.00%19:10 EDT
Volume:670.18K
Turnover:2.81M
Market Cap:201.51M
PE:-1.37
High:4.36
Open:3.98
Low:3.97
Close:3.91
Loading ...
Feb 07, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jan 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Sep 13, 2023

Major Issues Report

Form 8-K - Current report
Aug 12, 2023

Correspondence

Form CORRESP - Correspondence
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 11, 2023

Major Issues Report

Form 8-K - Current report
Jun 05, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals